Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species

Cell Death and Differentiation

Volumn 21, Issue 3, 2014, Pages 388-396

  Su, J ^a   Chen, X ^a   Huang, Y ^a   Li, W ^a   Li, J ^a   Cao, K ^a   Cao, G ^a   Zhang, L ^b   Li, F ^a   Roberts, A I ^b   Kang, H ^a   Yu, P ^a   Ren, G ^b   Ji, W ^c   Wang, Y ^a   Shi, Y ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

3 dioxygenase; immunosuppression; indoleamine 2; inducible nitric oxide synthase; mammalian phylogeny; mesenchymal stem cells

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENETICS; HAMSTER; HAPLORHINI; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; MOUSE; PHYLOGENY; PHYSIOLOGY; RABBIT; RAT; SPRAGUE DAWLEY RAT; SWINE;

ANIMALS; CELL DIFFERENTIATION; CRICETINAE; DISEASE MODELS, ANIMAL; HAPLORHINI; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PHYLOGENY; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 84893824227     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.149     Document Type: Article

References (48)

1. Torensma R, Prins HJ, Schrama E, Verwiel ET, Martens AC, Roelofs H et al. The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. Stem Cells Dev 2012; 22: 1086-1096
2. Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G et al. Short-Term, long-Term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2012; 68: 475-484
3. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9: 641-650
4. Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graftversus-host disease. Biol Blood Marrow Transplant 2009; 15: 804-811
5. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA. Adipose tissuederived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591
6. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009; 27: 1421-1432
7. Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis 2012; 71: 1733-1740
8. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P et al. Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair. Cell Res 2010; 20: 510-518
9. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012; 33: 136-143
10. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI et al. Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150
11. Li W, Ren G, Huang Y, Su J, Han Y, Li J et al. Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ 2012; 19: 1505-1513
12. Ren G, Su J, Zhang L, Zhao X, Ling W, Lhuillie A et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27: 1954-1962
13. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007; 109: 228-234
14. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007; 149: 353-363
15. Xuqian W, Kanghua L, Weihong Y, Xi Y, Rongping D, Qin H et al. Intraocular transplantation of human adipose-derived mesenchymal stem cells in a rabbit model of experimental retinal holes. Ophthalmic Res 2011; 46: 199-207
16. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, Buadze M et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 2011; 14: 3-16
17. Chang CH, Kuo TF, Lin FH, Wang JH, Hsu YM, Huang HT et al. Tissue engineering-based cartilage repair with mesenchymal stem cells in a porcine model. J Orthop Res 2011; 29: 1874-1880
18. Sharma AK, Bury MI, Marks AJ, Fuller NJ, Meisner JW, Tapaskar N et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. Stem Cells 2011; 29: 241-250
19. Hu J, Zhu QT, Liu XL, Xu YB, Zhu JK. Repair of extended peripheral nerve lesions in rhesus monkeys using acellular allogenic nerve grafts implanted with autologous mesenchymal stem cells. Exp Neurol 2007; 204: 658-666
20. You Q, Cai L, Zheng J, Tong X, Zhang D, Zhang Y. Isolation of human mesenchymal stem cells from third-Trimester amniotic fluid. Int J Gynaecol Obstet 2008; 103: 149-152
21. Comite P, Cobianchi L, Avanzini MA, Zonta S, Mantelli M, Achille V et al. Isolation and ex vivo expansion of bone marrow-derived porcine mesenchymal stromal cells: Ootential for application in an experimental model of solid organ transplantation in large animals. Transplant Proc 2010; 42: 1341-1343
22. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A et al. Role for interferongamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386-398
23. Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 2007; 17: 240-248
24. Sudres M, Norol F, Trenado A, Gregoire S, Charlotte F, Levacher B et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graftversus-host disease in mice. J Immunol 2006; 176: 7761-7767
25. Gieseke F, Bohringer J, Bussolari R, Dominici M, Handgretinger R, Muller I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010; 116: 3770-3779
26. Hegyi B, Kudlik G, Monostori E, Uher F. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells. Biochem Biophys Res Commun 2012; 419: 215-220
27. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619-4621
28. Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Whartons Jelly and bone marrow sources. Cell Immunol 2010; 264: 171-179
29. Groh ME, Maitra B, Szekely E, Koc ON. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005; 33: 928-934
30. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822
31. Chabannes D, Hill M, Merieau E, Rossignol J, Brion R, Soulillou JP et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007; 110: 3691-3694
32. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843
33. Chan CK, Wu KH, Lee YS, Hwang SM, Lee MS, Liao SK et al. The comparison of interleukin 6-Associated immunosuppressive effects of human ESCs, fetal-Type MSCs, and adult-Type MSCs. Transplantation 2012; 94: 132-138
34. Nasef A, Mazurier C, Bouchet S, Francois S, Chapel A, Thierry D et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 2008; 253: 16-22
35. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4bCD25highFOXP3+ regulatory T cells. Stem Cells 2008; 26: 212-222
36. Zinocker S, Vaage JT. Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase. Front Immunol 2012; 3: 62
37. Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D et al. Human versus porcine mesenchymal stromal cells: Ohenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med 2012; 16: 1827-1839
38. Zhu F, Guo GH, Chen W, Peng Y, Xing JJ, Wang NY. Effect of bone marrow-derived mesenchymal stem cells transplantation on the inflammatory response and lung injury in rabbit with inhalation injury. Zhonghua Shao Shang Za Zhi 2010; 26: 360-365
39. Houlihan DD, Hopkins LJ, Suresh SX, Armstrong MJ, Newsome PN. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-Term and long-Term outcomes. Hepatology 2011; 54: 1891-1892; author reply 1892
40. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-1205
41. Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 702-708
42. Ishikawa H, Jo JI, Tabata Y. Liver anti-fibrosis therapy with mesenchymal stem cells secreting hepatocyte growth factor. J Biomater Sci Polym Ed. 2012; 23: 2259-2272
43. Pal R, Gopinath C, Rao NM, Banerjee P, Krishnamoorthy V, Venkataramana NK et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 2010; 12: 792-806
44. Perin EC, Tian M, Marini FC 3rd, Silva GV, Zheng Y, Baimbridge F et al. Imaging long-Term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS ONE 2011; 6: E22949
45. Song S, Liu L, Edwards SV, Wu S. Resolving conflict in eutherian mammal phylogeny using phylogenomics and the multispecies coalescent model. Proc Natl Acad Sci USA 2012; 109: 14942-14947
46. Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425
47. Yuasa HJ, Takubo M, Takahashi A, Hasegawa T, Noma H, Suzuki T. Evolution of vertebrate indoleamine 2,3-dioxygenases. J Mol Evol 2007; 65: 705-714
48. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, Miu J et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 2007; 396: 203-213